Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00727857 · ClinicalTrials.gov registry record · Phase 3

Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.

A Phase 3 study of Diabetes Mellitus, sponsored by Takeda.

Completed
Registry status
Phase 3
Development phase
600
Enrollment target
20
Study locations

NCT00727857 is a Phase 3 study of Diabetes Mellitus that has completed, run by Takeda. The registered enrollment target is 600 participants, below the 1,865-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (68% lower). The trial reports 20 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00727857, a Phase 3 study of Diabetes Mellitus, has completed, sponsored by Takeda.

COMPLETED
Registry status
Phase 3
Development phase
600 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to determine the efficacy of pioglitazone, twice daily (BID), combined with metformin versus pioglitazone taken alone and metformin taken alone in treating Type 2 Diabetes Mellitus.

Conditions Studied

Diabetes Mellitus

Interventions

  • DRUG Metformin
  • DRUG Pioglitazone
  • DRUG Pioglitazone and metformin

Study Locations (20)

California

  • - Anaheim
  • - Artesia
  • - Dinuba
  • - Long Beach
  • - Los Angeles
  • - Norwalk
  • - Orange
  • - Santa Ana
  • - Santa Monica

Alabama

  • - Birmingham
  • - Haleyville
  • - Montgomery
  • - Pell City

Florida

  • - Altamonte Springs
  • - Coral Gables
  • - Hialeah
  • - Miami

Arizona

  • - Phoenix
  • - Tucson

Colorado

  • - Pueblo

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2007-06
Est. Completion 2008-08
Phase Phase 3

Sponsor

Takeda

408 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00727857

The ClinicalTrials.gov registry entry for NCT00727857 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,865-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (68% lower). The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 3 interventions - of which Metformin is the first listed.

NCT00727857 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Alabama, Florida.

Frequently Asked Questions

What is clinical trial NCT00727857 about?

NCT00727857 is a clinical study titled "Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.". The purpose of this study is to determine the efficacy of pioglitazone, twice daily (BID), combined with metformin versus pioglitazone taken alone and metformin taken alone in treating Type 2 Diabetes Mellitus.

What is the current status of trial NCT00727857?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 600 participants. The study started on 2007-06. Estimated completion is 2008-08.

What conditions does trial NCT00727857 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT00727857?

The interventions under investigation include: Metformin (DRUG), Pioglitazone (DRUG), Pioglitazone and metformin (DRUG).

Who is sponsoring clinical trial NCT00727857?

This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00727857 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.